Home » APPLIED IMAGING ANNOUNCES FDA CLEARANCE TO MARKET GENETIC PROBE TEST
APPLIED IMAGING ANNOUNCES FDA CLEARANCE TO MARKET GENETIC PROBE TEST
Applied Imaging has received 510(k) clearance from the FDA to market its automated application for Chromosome X and Chromosome Y analysis in bone marrow transplant patients. Applied Imaging's CytoVision system will utilize this application to enumerate tests that are important indicators in evaluating the viability of opposite-sex bone marrow transplants.
ArriveNet
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct